000			01817 a2200517 4500
005			20250517092703.0
264		0	_c20160516
008			201605s 0 0 eng d
040			_aNLM _beng _cNLM
100	1		_aSteiner, David J
245	0	0	_aPharmaceuticals and Medical Devices: Cost Savings. _h[electronic resource]
260			_bIssue brief (Health Policy Tracking Service) _cDec 2015
300			_a1-31 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBiosimilar Pharmaceuticals _xeconomics
650	0	4	_aCanada
650	0	4	_aCardiovascular Diseases _xdrug therapy
650	0	4	_aCommerce
650	0	4	_aContraceptive Agents _xeconomics
650	0	4	_aCost Savings
650	0	4	_aDeductibles and Coinsurance _xeconomics
650	0	4	_aDrug Costs _xlegislation & jurisprudence
650	0	4	_aDrugs, Generic _xeconomics
650	0	4	_aEconomics, Pharmaceutical _xlegislation & jurisprudence
650	0	4	_aElectronic Prescribing _xeconomics
650	0	4	_aFederal Government
650	0	4	_aFormularies as Topic
650	0	4	_aHealth Benefit Plans, Employee
650	0	4	_aHealth Insurance Exchanges
650	0	4	_aHealth Services Accessibility
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInsurance, Pharmaceutical Services
650	0	4	_aLegislation, Drug _xeconomics
650	0	4	_aMedicaid
650	0	4	_aMedication Adherence
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPatient Protection and Affordable Care Act
650	0	4	_aPharmacies _xeconomics
650	0	4	_aPrescription Drugs _xeconomics
650	0	4	_aSoftware
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
773	0		_tIssue brief (Health Policy Tracking Service) _gp. 1-31
999			_c25961059 _d25961059